Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MCP3 | 26.0 | 75 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MCP3 | 31.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MCP3 | 104.5 | 62 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | MCP3 | 103.0 | 57 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MCP3 | 43.0 | 74 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | MCP3 | 47.0 | 70 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MCP3 | 130.0 | 89 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | MCP3 | 91.0 | 63 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 19.0 | 67 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 22.0 | 75 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 19.0 | 70 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 19.0 | 73 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 19.0 | 91 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 18.0 | 73 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 23.0 | 68 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 22.0 | 53 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 24.0 | 66 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 32.5 | 62 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 29.0 | 53 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 31.0 | 45 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MCP3 | 21.5 | 52 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | MCP3 | 20.0 | 79 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MCP3 | 21.0 | 99 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | MCP3 | 20.0 | 80 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MCP3 | 18.5 | 74 |